SWOG S2303 PARAMUNE

S2303 #PARAMUNE trial tests an anti-VEGFR2 + anti-PD1/L1 combo in patients w #gastric, #GEJ, or esophageal #adenocarcinoma whose dx progressed on (or who were intolerant to) 1st-line chemo + PD1/L1 inhibitor.
swog.org/clinical-tri...
Co-PI: Paul Oberstein, MD
@nyulangone.bsky.social
#gicsm #esocsm

S2303 PARAMUNE clinical trial

Enrolling: #PARAMUNE @SWOG S2303 ph 2/3 randomized #clinicaltrial of paclitaxel + ramucirumab w/wo nivolumab in patients w advanced MSS, HER2- #gastric, #GEJ, or #esophageal #adenocarcinoma w PD-L1 CPS ≥ 1.
SWOG.org/clinical-trials/S2303
PI: Anwaar Saeed, MD @upmchillmancc.bsky.social #esocsm #gicsm

SWOG S2303 study

Do you have #esophageal or #stomach #cancer that has spread or can’t be removed with surgery? If initial treatment didn’t work or stopped working, study S2303 may be an option for you.
SWOG.org/S2303. 1-800-4-CANCER. #esocsm #stcsm #gicsm #PARAMUNE